ArticleInfection and immunity2012

Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.

Constantine Bitsaktsis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.